|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-9-10
|
|
pubmed:abstractText |
alphaB-crystallin is an anti-apoptotic protein commonly expressed in poor prognosis basal-like breast tumors, which are largely triple (estrogen receptor (ER), progesterone receptor (PR), and HER2) negative. We examined whether alphaB-crystallin expression in breast cancer was associated with a poor response to neoadjuvant (preoperative) chemotherapy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Crystallin B Chain
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0167-6806
|
|
pubmed:author |
pubmed-author:CrynsVincent LVL,
pubmed-author:DiazLeslie KLK,
pubmed-author:GradisharWilliam JWJ,
pubmed-author:IvanovOlgaO,
pubmed-author:KeswaniAnjeniA,
pubmed-author:KhanSeema ASA,
pubmed-author:MemmelHeidi CHC,
pubmed-author:MorrowMonicaM,
pubmed-author:RademakerAlfredA,
pubmed-author:WileyElizabeth LEL,
pubmed-author:YuZ PZP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
111
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
411-7
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17968656-Adult,
pubmed-meshheading:17968656-Aged,
pubmed-meshheading:17968656-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17968656-Breast Neoplasms,
pubmed-meshheading:17968656-Chemotherapy, Adjuvant,
pubmed-meshheading:17968656-Drug Resistance, Neoplasm,
pubmed-meshheading:17968656-Female,
pubmed-meshheading:17968656-Humans,
pubmed-meshheading:17968656-Male,
pubmed-meshheading:17968656-Middle Aged,
pubmed-meshheading:17968656-Neoadjuvant Therapy,
pubmed-meshheading:17968656-Receptor, erbB-2,
pubmed-meshheading:17968656-Receptors, Estrogen,
pubmed-meshheading:17968656-Receptors, Progesterone,
pubmed-meshheading:17968656-Treatment Failure,
pubmed-meshheading:17968656-Tumor Markers, Biological,
pubmed-meshheading:17968656-alpha-Crystallin B Chain
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
|
|
pubmed:affiliation |
Department of Surgery, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
